The SQUID Trial for the Embolization of the Middle Meningeal Artery (STEM) for Treatment of Chronic Subdural Hematoma

Brief description of study

The purpose of this research study is to study the safety and efficacy of embolization (how well it works) to treat middle meningeal artery (MMA) bleeds using SQUID, a liquid particle embolic agent.


Clinical Study Identifier: s21-01641
ClinicalTrials.gov Identifier: NCT04410146
Principal Investigator: Erez Nossek.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.